- Release Date: 03/09/21 11:41
- Summary: FDA grants Orphan Drug designation for Prader-Willi syndrome
- Price Sensitive: Yes
- Download Document 152.03KB
- Forums
- ASX - By Stock
- NEU
- Ann: FDA grants Orphan Drug designation for Prader-Willi syndrome
Ann: FDA grants Orphan Drug designation for Prader-Willi syndrome
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$16.49 |
Change
-0.545(3.20%) |
Mkt cap ! $2.106B |
Open | High | Low | Value | Volume |
$16.94 | $17.02 | $16.38 | $8.026M | 481.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 1425 | $16.47 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.49 | 53 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 716 | 16.440 |
10 | 1054 | 16.430 |
12 | 1271 | 16.420 |
5 | 722 | 16.410 |
5 | 1280 | 16.400 |
Price($) | Vol. | No. |
---|---|---|
16.460 | 373 | 4 |
16.470 | 602 | 6 |
16.480 | 653 | 4 |
16.490 | 528 | 3 |
16.500 | 686 | 4 |
Last trade - 15.33pm 13/11/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online